Biophysical aspects and biological implications of the interaction of benzophenanthridine alkaloids with DNA

Biophysical Reviews

Volumn 1, Issue 3, 2009, Pages 119-129

  Maiti, Motilal ^a   Kumar, Gopinatha Suresh ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Alkaloid DNA interactions; Chelerythrine; Fagaronine; Nitidine; Polymorphic DNA structures; Sanguinarine

Indexed keywords

EID: 77953589561     PISSN: 18672450     EISSN: 18672469     Source Type: Journal    
DOI: 10.1007/s12551-009-0014-7     Document Type: Review

References (70)

1. Adhami VM, Aziz MH, Reagan-Shaw SR, Nihal M, Mukhtar H, Ahmad N (2004) Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther 3: 933-940.
2. Adhikari A, Hossain M, Maiti M, Kumar GS (2008) Energetics of the binding of phototoxic and cytotoxic plant alkaloid sanguinarine to DNA: isothernmal titration calorimetric studies. J Mol Struct 899: 54-63.
3. Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H (2000) Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 6: 1524-1528.
4. Babich H, Zukerbraun HL, Barber IB, Babich SB, Borenfreund E (1996) Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacol Toxicol 78: 397-403.
5. Bai LP, Zhao ZZ, Cai Z, Jiang ZH (2006) DNA binding affinities and sequence selectivity of quaternary benzophenanthrine alkaloids sanguinarine, chelerythrine, and nitidine. Bioorg Med Chem 14: 5439-5445.
6. Bajaj NP, McLean MJ, Waring MJ, Smekal E (1990) Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids. J Mol Recog 3: 48-54.
7. Barret Y, Samvaire Y (2006) Fagaronine a novel antileukemic alklaoid. Phytother Res 6: 59-63.
8. Benoist H, Comoe L, Joly P, Carpenter Y, Desplaces A, Dufer J (1989) Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer. Cancer Immunol Immunother 30: 289-294.
9. Cabrespine A, Bay JO, Barthomeuf C, Curé H, Chollet P, Debiton E (2005) In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment. Anticancer Drug 16: 417-422.
10. Chang YC, Chang FR, Khalil AT, Hsiesh PW, Wu YC (2003) Cytotoxic benzophenanthridine and benzylisoquinoline alkaloids from Argemone mexicana. Z Naturforsch 58: 521-526.
11. Chen FM (1984) Base protonation facilitates B-Z interconversions of poly(dG-dC). poly(dG-dC). Biochemistry 23: 6159-6165.
12. Chen WH, Qin Y, Cai Z, Chan CL, Luo GA, Jiang ZH (2005) Spectrometric studies of cytotoxic protoberberine alkaloids binding to double-stranded DNA. Bioorg Med Chem 13: 1859-1866.
13. Das S (2000) Biophysical studies on the interactions of benzophenanthridine alkaloids with polymorphic nucleic acid structures. PhD Thesis, Jadavpur University, Kolkata.
14. Das M, Khanna SK (1997) Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. Crit Rev Toxicol 27: 273-297.
15. Das S, Kumar GS, Maiti M (1999) Conversions of the left-handed and protonated form of DNA back to the bound right-handed form by sanguinarine and ethidium: a comparative study. Biophys Chem 76: 199-218.
16. Das S, Kumar GS, Ray A, Maiti M (2003) Spectroscopic and thermodynamic studies on the binding of sanguinarine and berberine to triple and double helical DNA and RNA structures. J Biomol Struct Dyn 20: 703-714.
17. Denny WA (1989) DNA-intercalating ligands as anti-cancer drugs: prospects for future design. Anticancer Drug Des 4: 241-263.
18. Faddejeva MD, Belyaeva TN, Rosanov Yu M, Sedova M, Sokolovskaya EL (1984) Studies on the complex formation with DNA and the effect on DNA hydrolysis, RNA syhthesis and cellular membrane ATPase system of some antitumor alkaloids. Stud Biophys 104: 267-269.
19. Gallagher K, Sharp K (1998) Electrostatic contributions to heat capacity changes of DNA-ligand binding. Biophys J 75: 769-776.
20. Giuliana G, Pizzo G, Milici ME, Musotto GC, Giangreco R (1997) In vitro antifungal properties of mouthrinses containing antimicrobial agents. J Periodontol 68: 729-733.
21. Hélène C (1991) The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anticancer Drug Des 6: 569-584.
22. Holden JA, Wall ME, Wani MC, Manikumar G (1999) Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage. Arch Biochem Biophys 370: 66-76.
23. Holy J, Lamont G, Perkins E (2006) Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine. BMC Cell Biol 7: 13-26.
24. Hossain M (2009) Biophysical studies on the interaction of intercalating and groove binding molecules with deoxyribonucleic acids. PhD Thesis, Jadavpur University, Kolkata.
25. Hossain M, Kumar GS (2009) DNA binding of benzophenanthridine compounds sanguinarine versus ethidium: comparative binding and thermodynamic profile of intercalation. J Chem Thermodyn 41: 764-774.
26. Hurley LH (2002) DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2: 188-200.
27. Hussain AR, Al-Jomah NA, Siraj AK, Manogaran P, Al-Hussein K, Abubaker J, Platanias LC, Al-Kuraya KS, Uddin S (2007) Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res 67: 3888-3897.
28. Ianoul A, Fleuny F, Dural O, Waigh R, Jardiller JC, Alix AJP, Nabier I (1999) DNA binding by fagaronine and ethoxidine, inhibitors of human DNA topoisomerases I and II, probes by SERS and flow linear dichroism spectroscopy. J Phys Chem B 103: 2008-2013.
29. Janin YL, Croisy A, Riou JF, Bisagni E (1993) Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives. J Med Chem 36: 3686-3692.
30. Jones RP, Harkrader RJ, Southard GL (1986) The effect of pH on sanguinarine iminium ion form. J Nat Prod 49: 1109-1111.
31. Jovin TM, Soumpasis DM, McIntosh LP (1987) The transition between B-DNA and Z-DNA. Annu Rev Phys Chem 38: 521-558.
32. Kaminskyy VO, Lin KW, Filyak Y, Stoika RS (2008) Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells. Cell Biol Int 32: 1271-277.
33. Kassim OO, Loyevsky M, Elliott B, Geall A, Amonoo H, Gordeuk VR (2005) Effects of root extracts of Fagara zanthoxyloides on the in vitro growth and stage distribution of Plasmodium falciparum. Antimicrob Agents Chemother 49: 264-268.
34. Kumar GS, Maiti M (1994) DNA polymorphism under the influence of low pH and low temperature. J Biomol Struct Dyn 12: 183-201.
35. Latimer LJP, Payton N, Forsyth G, Lee JS (1995) The binding of analogues of coralyne and related heterocyclics to DNA triplexes. Biochem Cell Biol 73: 11-18.
36. L-form structures. Indian J Biochem Biohys 38: 20-26.
37. Maiti M, Kumar GS (2007a) Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Med Res Rev 27: 649-695.
38. Maiti M, Kumar GS (2007b) Protoberberine alkaloids: physicochemical and nucleic acid binding properties. Top Heterocycl Chem 10: 155-209.
39. Maiti M, Nandi R (1987) Circular dichroism of sanguinarine-DNA complexes: effect of base composition, pH and ionic strength. J Biomol Struct Dyn 5: 159-175.
40. Maiti M, Nandi R, Chaudhuri K (1982) Sanguinarine: a monofunctional intercalating alkaloid. FEBS Lett 142: 280-284.
41. Maiti M, Nandi R, Chaudhuri K (1983) The effect of pH on the absorption and fluorescence of sanguinarine. Photochem Photobiol 38: 245-249.
42. Maiti M, Nandi R, Chaudhuri K (1984) Interaction of sanguinarine with natural and synthetic deoxyribonucleic acids. Indian J Biochem Biophys 21: 158-165.
43. Maiti M, Das S, Sen A, Kumar GS, Nandi R (2002) Influence of DNA structures on the conversion of sanguinarine alkanolamine form to iminium form. J Biomol Struct Dyn 20: 455-464.
44. Malikova J, Zdarilova A, Hlobikova A (2006) Effect of sanguinarine and chelerythrine on cell cycle and apoptosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150: 5-12.
45. Moterich IG, Strekal ND, Nowicky JW, Maskerich SA (2007) Absorption, fluorescence and SERS spectra of sanguinarine at different pH values. J Appl Spectrosc 74: 666-672.
46. Nafao Y, Sano S, Miyasaka T, Ochiai M, Fiji K, Fujita E, Ishii H (1985) Evaluation of the affinity of new N atom-containing tumor inhibitors for nucleic acids. Nucleic Acids Sym Ser 16: 37-40.
47. Nandi R, Maiti M (1985) Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochem Pharmacol 34: 321-324.
48. Novak RM, Keyer KA, Kinghorn AD, Pezzuto JM (1991) Antiviral activity of the plant compound fagaronine chloride, a reverse transcriptase inhibitor in HIV-infected peripheral blood mononuclear cells and T cell lines. Int Conf AIDS 7: 11-12.
49. Pezzuto JM, Antosiak SK, Messmer WM, Slaytor MB, Honig GR (1983) Interaction of the antileukemic alkaloid, 2-hydroxy-3, 8, 9-trimethoxy-5-methylbenzo[c]phenanthridine (fagaronine), with nucleic acids. Chem Biol Interact 43: 323-329.
50. Pohl FM, Jovin TM (1972) Salt-induced co-operative conformational change of a synthetic DNA: equilibrium and kinetic studies with poly (dG-dC). J Mol Biol 67: 375-396.
51. Prado S, Michel S, Tillequin F, Koch M, Pfeiffer B, Pierre A, Leonce S, Colson P, Baldeyrou B, Lansiaux A, Bailly C (2004) Synthesis and cytotoxic activity of benzo[c][1, 7] and [1, 8]phenanthrolines analogues of nitidine and fagaronine. Bioorg Med Chem 12: 3943-3953.
52. Qin Y, Pang J, Chen WH, Cai Z, Jiang ZH (2006) Synthesis, DNA-binding affinities, and binding mode of berberine dimers. Bioorg Med Chem 14: 25-32.
53. Ray A, Kumar GS, Das S, Maiti M (1999) Spectroscopic studies on the interaction of aristololactam-β-D glucoside with DNA and RNA double and triple helices: a comparative study. Biochemistry 38: 6239-6247.
54. Ren J, Chaires JB (1999) Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry 38: 16067-16075.
55. Saenger W (1984) Principles of nucleic acids structure. Springer-Verlag, New York.
56. Saran A, Srivastava S, Coutinho E, Maiti M (1995) 1H NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian J Biochem Biophys 32: 74-77.
57. Segers-Nolten GM, Sijtsema NM, Otto C (1997) Evidence for Hoogsteen GC base pairs in the proton-induced transition from right-handed to left-handed poly(dG-dC). poly(dG-dC). Biochemistry 36: 13241-13247.
58. Sen A, Maiti M (1994) Interaction of sanguinarine iminium and alkanolamine form with calf thymus DNA. Biochem Pharmacol 48: 2097-2102.
59. Sen A, Ray A, Maiti M (1996) Thermodynamics of the interactions of sanguinarine with DNA: influence of ionic strength and base composition. Biophys Chem 59: 155-170.
60. Serafim TL, Matos JAC, Sardão VA, Pereira GC, Branco AF, Pereira SL, Parke D, Perkins EL, Moreno AJM, Holy J, Oliveira PJ (2008) Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells-nuclear vs. mitochondrial effects. Biochem Pharmacol 76: 1459-1475.
61. Smekal E, Kubova N, Kleinwatcher V (1984) Interaction of benzophenanthridine alkaloid sanguinarine with DNA. Stud Biophys 114: 125-132.
62. Southard GL, Boulware RT, Walborn DR, Groznik WJ, Thorne EE, Yankell SL (1987) Sanguinarine, a new antiplaque agent: retention and plaque specificity. J Am Dent Assoc 108: 338-341.
63. Stiborova M, Simanek V, Frei E, Hobza P, Ulrichova J (2002) DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. Chem Biol Interact 140: 231-242.
64. Tajmir-Riahi HA, Neault JF, Naoui M (1995) Does DNA acid fixation produce left-handed Z structure? FEBS Lett 370: 105-108.
65. Todor IN (2003) The effect of the antineoplastic drug Ukrain on the electrokinetic potential of malignant and normal cells. Int J Immunother 19: 159-167.
66. Urbanova J, Lubal P, Slaninova I, Taborska E, Taborsky P (2009) Fluorescence properties of selected benzo[c]phenanthridine alkaloids and studies of their interaction with CT DNA. Anal Bioanal Chem. doi: 10. 1007/s00216-009-2601-7.
67. Vogt A, Tamewitz A, Skoko J, Sikorski PP, Giuliano KA, Lazo JS (2005) The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem 280: 19078-19086.
68. Wang LK, Johnson RK, Hecht SM (1993) Inhibition of topoisomerase I function by nitidine and fagaronine. Chem Res Toxicol 6: 813-818.
69. Waring MJ (1981) DNA modification and cancer. Annu Rev Biochem 50: 159-192.
70. Wolff J, Knipling L (1993) Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry 32: 13334-13339.